The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
The IPOs of Emcure Pharmaceuticals, sopra which shark tank brama Namita Thapar is the Director and Bansal Wire will gara open for subscription next week sopra the mainboard segment, while Ambey Laboratories is the SME issue.
Apart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, which received healthy investors‘ response for their IPOs sopra the week gone by.
Analysts expect significant capital to be deployed sopra public markets and strong demand for both new-age and conventional companies sopra coming months.
Here’s what to aspetto forward to acceso the IPO front next weekEmcure Pharmaceuticals IPO
The initial public offer (IPO) of Emcure Pharmaceuticals will gara open for subscription July 3 and will close acceso July 5. The company has fixed a price of Rs 960-1008 secondo share.
The IPO comprises a fresh issuance of equity shares worth Rs 800 crore and an Offer of Sensatezza (OFS) of 1.14 crore equity shares by promoters and existing shareholders, according to the draft red herring prospectus filed sopra December.Those selling shares sopra the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.92% stake sopra the company and BC Investments owns a 13.09% stake.
Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Pune-based firm Emcure Pharmaceuticals is engaged sopra developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Kotak Mahindra Capital Company, Jefferies India, Axis Capital, and JP Morgan India are the book-running lead managers to the issue.
Bansal Wire IPO
The initial public offer (IPO) of Bansal Wire will gara open for subscription acceso July 3 and close acceso July 5. The company has fixed a price of Rs 243-256 secondo share.
At the upper end, the company plans to raise around Rs 745 crore. Investors can bid for 58 shares sopra one lot and sopra multiples thereafter.
The public offer is being made through the book building process, wherein about 50% of the issue is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.
The company proposes to use the funds from the IPO to repay some of its debt, working capital requirements and other general corporate purposes.
Bansal Wire is the largest stainless steel wire manufacturing company and the second largest steel wire manufacturing company by tono sopra India with a production of 72,176 MTPA and 206,466 MTPA, respectively, sopra FY23.
Ambey Laboratories SME IPO
The Rs 45 crore SME IPO of Ambey Laboratories will gara open for subscription acceso July 4. The issue, which is a combination of fresh equity restare di sale of 62.5 lakh shares and an offer for restare di sale (OFS) of 3.12 lakh shares, closes acceso July 8.
The IPO is priced sopra the range of Rs 65-68, where investors can bid for 2,000 shares sopra one lot.
